Cited2 inhibited hypoxia-induced proliferation and migration of PASMCs via the TGF-β1/Cited2/PPARγ pathway

Document Type : Original Article


1 The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, Gansu, China

2 Department of Respiratory Medicine, Gansu Provincial Hospital, Lanzhou 730000, Gansu, China

3 Department of Plateau Medical Center, Qinghai University, Xining 810000, Qinghai, China

4 Department of Respiratory Medicine, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu, China


Objective(s): Proliferation and migration of pulmonary artery smooth muscle cells (PASMCs) contribute to hypoxia-induced pulmonary hypertension (HPH). The transcription factor Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) has been implicated in the control of tumor cells and mesenchymal stem cell (MSC) and cardiomyocyte growth or migration. Whether Cited2 is involved in the proliferation and migration of PASMCs and the underlying mechanisms deserve to be explored. 
Materials and Methods: Cited2 expression was detected in rat PASMCs under hypoxia conditions and HPH rat models. The effect of Cited2 on the proliferation and migration of PASMC was detected by overexpression or knockdown of the Cited2 gene. After PAMSCs were treated with recombinant TGF-β1 and the lentivirus vector overexpressing Cited2, expression of peroxisome proliferator-activated receptor gamma (PPARγ) was examined by western blotting.
Results: We revealed that hypoxia down-regulated the expression of Cited2 in PASMCs and rat pulmonary arteries. Cited2 overexpression inhibited the proliferation and migration of PASMCs under hypoxia, while Cited2 knockdown induced the proliferation and migration of PASMCs. Cited2 inhibits the negative regulation of the TGF-β1 pathway on PPARγ to inhibit the proliferation and migration of PASMCs.
Conclusion: These findings suggest that increased Cited2 expression contributes to the inhibition of PASMCs proliferation and migration by regulating TGF-β1-mediated target gene expression in HPH and provides a new target for molecular therapy of HPH.


Main Subjects

1. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015;46:903-975.
2. Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J 2019;53 :1801914-1801928.
3. Wilkins MR, Ghofrani HA, Weissmann N, Aldashev A, Zhao L. Pathophysiology and treatment of high-altitude pulmonary vascular disease. Circulation 2015;131:582-590.
4. Penumatsa KC, Singhal AA, Warburton RR, Bear MD, Bhedi CD, Nasirova S, et al. Vascular smooth muscle ROCK1 contributes to hypoxia-induced pulmonary hypertension development in mice. Biochem Biophys Res Commun 2022;604:137-143.
5. Shi Y, Jiang R, Qin X, Gao A, Hou X, Chen L, et al. Up-regulation of nPKC contributes to proliferation of mice pulmonary artery smooth muscle cells in hypoxia-induced pulmonary hypertension. Eur J Pharmacol 2021;900:174046.
6. Imakawa K, Dhakal P, Kubota K, Kusama K, Chakraborty D, Karim Rumi MA, et al. CITED2 modulation of trophoblast cell differentiation: insights from global transcriptome analysis. Reproduction 2016;151:509-516.
7. Fernandes MT, Calado SM, Mendes-Silva L, Braganca J. CITED2 and the modulation of the hypoxic response in cancer. World J Clin Oncol 2020;11:260-274.
8. Wu Q, Liu Q, Zhan J, Wang Q, Zhang D, He S, et al. Cited2 regulates proliferation and survival in young and old mouse cardiac stem cells. BMC Mol Cell Biol 2019;20:25-33.
9. Wu ZZ, Sun NK, Chao CC. Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis. J Cell Physiol 2011;226:2415-2428.
10. Gonzalez YR, Zhang Y, Behzadpoor D, Cregan S, Bamforth S, Slack RS, et al. CITED2 signals through peroxisome proliferator-activated receptor-gamma to regulate death of cortical neurons after DNA damage. J Neurosci 2008;28:5559-5569.
11. Wang X, Lockhart SM, Rathjen T, Albadawi H, Sorensen D, O’Neill BT, et al. Insulin down-regulates the transcriptional coregulator CITED2, an inhibitor of proangiogenic function in endothelial cells. Diabetes 2016;65:3680-3690.
12. Clark AL, Naya FJ. MicroRNAs in the myocyte enhancer factor 2 (MEF2)-regulated Gtl2-Dio3 noncoding RNA locus promote cardiomyocyte proliferation by targeting the transcriptional coactivator cited2. J Biol Chem 2015;290:23162-23172.
13. Machado-Oliveira G, Guerreiro E, Matias AC, Facucho-Oliveira J, Pacheco-Leyva I, Braganca J. FBXL5 modulates HIF-1alpha transcriptional activity by degradation of CITED2. Arch Biochem Biophys 2015;576:61-72.
14. Glenn DJ, Maurer RA. MRG1 binds to the LIM domain of Lhx2 and may function as a coactivator to stimulate glycoprotein hormone alpha-subunit gene expression. J Biol Chem 1999;274:36159-36167.
15. Braganca J, Eloranta JJ, Bamforth SD, Ibbitt JC, Hurst HC, Bhattacharya S. Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2. J Biol Chem 2003;278:16021-16029.
16. Mattes K, Berger G, Geugien M, Vellenga E, Schepers H. CITED2 affects leukemic cell survival by interfering with p53 activation. Cell Death Dis 2017;8:e3132-3141.
17. Zhang X, Chen W, Liu W, Li D, Shen W. CITED2 alleviates lipopolysaccharide-induced inflammation and pyroptosis in-human lung fibroblast by inhibition of NF-kappaB pathway. Allergol Immunopathol (Madr) 2022;50:64-70.
18. Chu WT, Chu X, Wang J. Investigations of the underlying mechanisms of HIF-1alpha and CITED2 binding to TAZ1. Proc Natl Acad Sci U S A 2020;117:5595-5603.
19. Wang RR, Yuan TY, Chen D, Chen YC, Sun SC, Wang SB, et al. Dan-shen-yin granules prevent hypoxia-induced pulmonary hypertension via STAT3/HIF-1alpha/VEGF and FAK/AKT Signaling Pathways. Front Pharmacol 2022;13:844400-844413.
20. Chen X, He Y, Yu Z, Zuo J, Huang Y, Ruan Y, et al. Polydatin glycosides improve monocrotaline-induced pulmonary hypertension injury by inhibiting endothelial-to-mesenchymal transition. Front Pharmacol 2022;13:862017-862028.
21. Ruiz-Ortiz I, De Sancho D. Competitive binding of HIF-1alpha and CITED2 to the TAZ1 domain of CBP from molecular simulations. Phys Chem Chem Phys 2020;22:8118-8127.
22. Sanada TJ, Sun XQ, Happe C, Guignabert C, Tu L, Schalij I, et al. Altered TGFbeta/SMAD signaling in human and rat models of pulmonary hypertension: An old target needs attention. Cells 2021;10:84-96.
23. Cao N, Liu X, Tang X, Gao R, Ma K, Li L, et al. [Emodin inhibits the proliferation and migration of human pulmonary artery smooth muscle cells by blocking SMAD2/3 signaling pathway]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022;38:707-713.
24. Hu C, Zhang Y, Tang K, Luo Y, Liu Y, Chen W. Down-regulation of CITED2 contributes to TGFbeta-mediated senescence of tendon-derived stem cells. Cell Tissue Res 2017;368:93-104.
25. Chou YT, Hsieh CH, Chiou SH, Hsu CF, Kao YR, Lee CC, et al. CITED2 functions as a molecular switch of cytokine-induced proliferation and quiescence. Cell Death Differ 2012;19:2015-2028.
26. Chou YT, Yang YC. Post-transcriptional control of Cited2 by transforming growth factor beta. Regulation via Smads and Cited2 coding region. J Biol Chem 2006;281:18451-18462.
27. Jayaraman S, Doucet M, Kominsky SL. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-beta-induced expression of VEGFA. Oncotarget 2017;8:6169-6178.
28. Chou YT, Wang H, Chen Y, Danielpour D, Yang YC. Cited2 modulates TGF-beta-mediated upregulation of MMP9. Oncogene 2006;25:5547-5560.
29. Liu HL, Yu D, Zhu ZN, Su SW, Chen XY, Zhang YJ. m-Nisodipine inhibited 5-HT-induced proliferation of rat PASMCs through Rho/ROCK signal pathway. Yao Xue Xue Bao 2015;50:824-829.
30. Sun Y, Guo HH, Guo DD, Jiang XY, Zou SM. Divergence of genes encoding CITED1 and CITED2 in blunt snout bream (megalobrama amblycephala) and their transcriptional responses to hypoxia. Front Physiol 2018;9:186-195.
31. Kim GD, Das R, Rao X, Zhong J, Deiuliis JA, Ramirez-Bergeron DL, et al. CITED2 restrains proinflammatory macrophage activation and response. Mol Cell Biol 2018;38:e00452-417.
32. Luo X, Ding L, Xu J, Chegini N. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology 2005;146:1097-1118.
33. Kang Y, Chen CR, Massague J. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 2003;11:915-926.
34. Zhang Y, Yuan RX, Bao D. TGF-beta1 promotes pulmonary arterial hypertension in rats via activating RhoA/ROCK signaling pathway. Eur Rev Med Pharmacol Sci 2020;24:4988-4996.
35. Cai G, Liu J, Wang M, Su L, Cai M, Huang K, et al. Mutual promotion of FGF21 and PPARgamma attenuates hypoxia-induced pulmonary hypertension. Exp Biol Med 2019;244:252-261.
36. Gong K, Xing D, Li P, Aksut B, Ambalavanan N, Yang Q, et al. Hypoxia induces down-regulation of PPAR-gamma in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-beta signaling. Am J Physiol Lung Cell Mol Physiol 2011;301:L899-907.
37. Calvier L, Chouvarine P, Legchenko E, Hoffmann N, Geldner J, Borchert P, et al. PPARgamma links BMP2 and TGFbeta1 pathways in vascular smooth muscle cells, regulating cell proliferation and glucose metabolism. Cell Metab 2017;25:1118-1134.
38. Tien ES, Davis JW, Vanden Heuvel JP. Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator. J Biol Chem 2004;279:24053-24063.
39. Victor Tseng, Roy L Sutliff, C Michael Hart. Redox biology of peroxisome proliferator-activated receptor-γ in pulmonary hypertension. Antioxid Redox Signal 2019;31:874-897.
40. Kylhammar D, Radegran G. The principal pathways involved in the in vivo modulation of hypoxic pulmonary vasoconstriction, pulmonary arterial remodelling and pulmonary hypertension. Acta Physiol (Oxf) 2017;219:728-756.
41. Christou H, Khalil RA. Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies. Am J Physiol Heart Circ Physiol 2022;322:H702-H24.
42. Liu YC, Chang PY, Chao CC. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene. Nucleic Acids Res 2015;43:10760-10781.
43. Niwa T. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120. Ther Apher Dial 2011;15:120-124.
44. Yang SL, Liu LP, Niu L, Sun YF, Yang XR, Fan J, et al. Down-regulation and pro-apoptotic effect of hypoxia-inducible factor 2 alpha in hepatocellular carcinoma. Oncotarget 2016;7:34571-34581.
45. Tanaka T, Yamaguchi J, Higashijima Y, Nangaku M. Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia. FASEB J 2013;27:4059-4075.
46. Beucken T, Magagnin MG, Savelkouls K, Lambin P, Koritzinsky M, Wouters BG. Regulation of Cited2 expression provides a functional link between translational and transcriptional responses during hypoxia. Radiother Oncol 2007;83:346-352.
47. Lou X, Sun S, Chen W, Zhou Y, Huang Y, Liu X, et al. Negative feedback regulation of NF-kappaB action by CITED2 in the nucleus. J Immunol 2011;186:539-548.
48. Xu B, Qu X, Gu S, Doughman YQ, Watanabe M, Dunwoodie SL, et al. Cited2 is required for fetal lung maturation. Dev Biol 2008;317:95-105.
49. Cao N, Aikeremu N, Shi WY, Tang XC, Gao RJ, Kong LJ, et al. Inhibition of KIR2.1 decreases pulmonary artery smooth muscle cell proliferation and migration. Int J Mol Med 2022;50:119-131.
50. Cao N, Tang X, Gao R, Kong L, Zhang J, Qin W, et al. Galectin-3 participates in PASMC migration and proliferation by interacting with TGF-beta1. Life Sci 2021;274:119347.
51. Liu Z, Wang Y, Dou C, Sun L, Li Q, Wang L, et al. MicroRNA-1468 promotes tumor progression by activating PPAR-gamma-mediated AKT signaling in human hepatocellular carcinoma. J Exp Clin Cancer Res 2018;37:49.
52. Zhang Q, Feng W, Wang Q, Wang J, Chai L, Chen Y, et al. PPARγ activation inhibits PDGF-induced pulmonary artery smooth muscle cell proliferation and migration by modulating TERT. Biomed Pharmacother 2022;152:113233.
53. Liu Y, Cao Y, Sun S, Zhu J, Gao S, Pang J, et al. Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways. Int J Biochem Cell Biol 2016;77:141-154.
54. Pan K, Lu J, Song Y. Artesunate ameliorates cigarette smoke-induced airway remodelling via PPAR-gamma/TGF-beta1/Smad2/3 signalling pathway. Respir Res 2021;22:91-103.